BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 515769)

  • 1. Clearance of lidocaine by hemodialysis.
    Vaziri ND; Saiki JK; Hughes W
    South Med J; 1979 Dec; 72(12):1567-8. PubMed ID: 515769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pruritus on hemodialysis.
    Tapia L
    Int J Dermatol; 1979 Apr; 18(3):217-8. PubMed ID: 457314
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
    Maduell F; Vera M; Arias M; Serra N; Blasco M; Bergadá E; Fontsere N; Cases A; Campistol JM
    Am J Kidney Dis; 2008 Jul; 52(1):85-92. PubMed ID: 18455852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
    Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
    Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
    Collinsworth KA; Strong JM; Atkinson AJ; Winkle RA; Perlroth F; Harrison DC
    Clin Pharmacol Ther; 1975 Jul; 18(1):59-64. PubMed ID: 1149363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate dosing of pilsicainide hydrochloride in patients on hemodialysis.
    Matsumoto M; Fujii Z; Kawata Y; Sakumura T; Minami M; Fujimoto K; Nawata C; Matsuzaki M
    Nephron; 2001 Jun; 88(2):134-7. PubMed ID: 11399915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uremic pruritus in chronic kidney failure with hemodialysis].
    Owada S; Toyama K; Maeba T; Ishida M
    Nihon Rinsho; 1992 Jan; 50 Suppl():867-72. PubMed ID: 1578780
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of theophylline by hemodialysis in one patient with chronic renal failure.
    Chang DB; Kuo SH; Yang PC; Shen FH; Luh KT
    Chest; 1992 Nov; 102(5):1621-3. PubMed ID: 1424911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
    Friga V; Linos A; Linos DA
    Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.
    Hasegawa G; Tsuruoka S; Ushijima K; Maeda A; Hayasaka T; Saito T; Harada K; Fujimura A
    Ther Apher Dial; 2017 Feb; 21(1):52-56. PubMed ID: 27629941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionic dialysance: principle and review of its clinical relevance for quantification of hemodialysis efficiency.
    Mercadal L; Ridel C; Petitclerc T
    Hemodial Int; 2005 Apr; 9(2):111-9. PubMed ID: 16191058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous lidocaine in the treatment of pruritus in hemodialysis patients.
    Joffe P; Andersen LW; Mølvig J; Kyst A; Johannessen A
    Clin Nephrol; 1985 Oct; 24(4):214. PubMed ID: 3905101
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodialyzability of acetazolamide.
    Vaziri ND; Saiki J; Barton CH; Rajudin M; Ness RL
    South Med J; 1980 Apr; 73(4):422-3. PubMed ID: 7367929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma histamine levels and kinetics in chronic hemodialysis patients.
    Poignet J; Callebert J; Delons S; Tabuteau F; Chauveau P; Bonete R; Launay JM; Man NK
    ASAIO Trans; 1989; 35(3):252-4. PubMed ID: 2597457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis.
    Kambia NK; Dine T; Odou P; Bah S; Azar R; Gressier B; Dupin-Spriet T; Luyckx M; Brunet C
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):225-30. PubMed ID: 15726882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.